ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients

This study has been terminated.
Study NCT00445328.   Last updated on October 30, 2008.   Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Venous Thromboembolism
2 Additional conditions recognized in this trial
Thromboembolism
3 More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Thrombosis
Vascular Diseases
4 Interventions listed in this trial
Dalteparin (Fragmin)
Unfractionated heparin
5 Additional drug interventions recognized in this trial
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
6 More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
7 Sponsors listed in this trial
Pfizer




Links to all studies - primarily for crawlers